We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.45 | -0.91% | 49.01 | 49.02 | 49.93 | 49.595 | 48.97 | 49.48 | 1,113,651 | 22:28:29 |
From May 2021 to May 2024
By Cecilia Butini
Sanofi SA said Thursday that it has named Viviane Monges as chair of the supervisory board of EUROAPI--its new company focused on active pharmaceutical ingredients for which an initial public offering is expected next year--and that it has made two further appointments to the executive committee.
The French pharma major said it appointed Roy Papatheodorou as executive vice president, general counsel and head of legal, ethics and business integrity. It has named Brendan O'Callaghan as executive vice president, global head of industrial affairs.
Ms. Monges's appointment is with immediate effect, Sanofi said. Mr. Papatheodorou will start in his role on Feb 1, 2022, while Mr. O'Callaghan will begin on Oct. 1.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
July 29, 2021 02:08 ET (06:08 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
